Top

Published in:

01-02-2019 | Breast Oncology

Treatment Intensity Differences According to Participation in a Population Screening Program

Authors: G. B. Mann, PhD, C. Nickson, PhD, K. Elder, PhD

Published in: Annals of Surgical Oncology | Issue 2/2019

Excerpt

We thank Dr. Lannin for his editorial interest1 in our paper ‘Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening Program’.2 We believe that much of his analysis stems from a misunderstanding of the nature of our study and a number of questionable assumptions. …

Lannin DR. Treatment Intensity for Mammographically Detected Tumours: An Alternative Viewpoint. Ann Surg Oncol. 2018;25(9):2502-2505.CrossRefPubMed

Elder K, et al. Treatment intensity differences after early-stage breast cancer (ESBC) diagnosis depending on participation in a screening program. Ann Surg Oncol. 2018;25(9):2563–72.CrossRefPubMed

Australian Institute of Health and Welfare. BreastScreen Australia monitoring report 2014–2015. Cancer series no. 106. Cat. no. CAN 105. Canberra, ACT: AIHW; 2017.

Welch HG, et al. Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med. 2016;375:1438–47.CrossRefPubMed

Puliti D, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen. 2012;19(Suppl 1):42–56.CrossRefPubMed

Marmot M, et al. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380:1778–86.CrossRef

Beckmann K, et al. Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects. J Med Screen. 2015;22:127–35.CrossRefPubMed

Martelotto LG, et al. Breast cancer intra-tumour heterogeneity. Breast Cancer Res. 2014;16:210.CrossRefPubMedPubMedCentral

Duffy S, et al. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study. Lancet Oncol. 2016;17:109–114.CrossRefPubMedPubMedCentral

10.

Bedrosian I. Screening mammography: getting to version 2.0. Ann Surg Oncol. 2018;25(9):2500–01.CrossRefPubMed

11.

Esserman L. The WISDOM Study: breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer. 2017;3:34.CrossRefPubMedPubMedCentral

Title: Treatment Intensity Differences According to Participation in a Population Screening Program
Authors: G. B. Mann, PhD
C. Nickson, PhD
K. Elder, PhD
Publication date: 01-02-2019
Publisher: Springer International Publishing
Published in: Annals of Surgical Oncology / Issue 2/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-018-07113-w

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Treatment Intensity Differences According to Participation in a Population Screening Program

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2019

Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience

Reply to “Differences in the Impact of Age on Mortality in Well-Differentiated Thyroid Cancer”

First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma

Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism

Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical Treatment

Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence? Response to the Preliminary Alliance 11102 Trial Report